Basso Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$228K Hold
3,656
– – 0.05% 147
2026
Q2
$211K Buy
3,656
+2,072
+131% +$119K 0.04% 135
2026
Q1
$96.1K Hold
1,584
– – 0.06% 79
2025
Q4
$85.4K Buy
+1,584
New +$76.2K 0.05% 75

Other funds holding BMY

Basso Capital Management's BMY Position: Q3 2026 in Review

Basso Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 3,656 shares worth $228K. The position accounts for 0.05% of the portfolio, ranked #147.

Basso Capital Management first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Basso Capital Management held 3,656 shares of Bristol-Myers Squibb worth $228K as of Q3 2026.
  • Basso Capital Management left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.05% of Basso Capital Management's portfolio in Q3 2026, its #147 holding.
  • Basso Capital Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Basso Capital Management's 13F filing for Q3 2026, filed 30 Oct 2026.